NCT00502801View on ClinicalTrials.gov

An Effectiveness, Safety, and Microbiology Study of Doripenem in Patients With Nosocomial (Hospital-acquired) Pneumonia

PHASE2CompletedINTERVENTIONAL

Enrollment

185

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions

PneumoniaBacterial PneumoniaVentilator-Associated PneumoniaInfections, Nosocomial

Interventions

DRUG

doripenem

1g i.v. infused over 4 hours every 8 hours for 8 to 14 days

Trial Locations (40)

Unknown

Palm Springs

San Francisco

Denver

Washington D.C.

Jacksonville

Miami

Atlanta

Decatur

Hazard

Baltimore

Springfield

Grand Rapids

Columbia

St Louis

Omaha

Buffalo

Flushing

Jamaica

Toledo

Providence

Johnson City

Nashville

Norfolk

Morgantown

Buenos Aires

Santa Fe

Oshawa

Chicoutimi

Concepción

Avenija Gojka Suska 6

Zagreb

Argenteuil 95 95

Jaipur

Kozhikode

Manipal

Noida

Pune

Novosibirsk

Kharkiv

Ukraine Poltava

All Listed Sponsors

lead

PriCara, Unit of Ortho-McNeil, Inc.

INDUSTRY

NCT00502801 - An Effectiveness, Safety, and Microbiology Study of Doripenem in Patients With Nosocomial (Hospital-acquired) Pneumonia | Biotech Hunter | Biotech Hunter